Longer-term Phase III data show Novartis drug Tasigna® continues to surpass Glivec® in slowing disease progression in patients
6 December 2010 | By Novartis
with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)...
List view / Grid view
6 December 2010 | By Novartis
with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)...
6 December 2010 | By ANDREW LLOYD & ASSOCIATES
Hybrigenics, today announces it has hired William Vickery as Head of Corporate and Business Development, a newly created position...
2 December 2010 | By kdm communications limited
Tecan’s HydroFlex microplate washer has allowed hematologists at the University of Modena & Reggio Emilia, to introduce automated washing for Enzyme-Linked ImmunoSpot assays...
2 December 2010 | By AstraZeneca
AstraZeneca announced the outcome of the US FDA Advisory Committee meeting...
2 December 2010 | By The Scott Partnership
The Scott Partnership has been appointed by Prism Ideas, ato lead the company's new international PR campaign...
1 December 2010 | By Johnson & Johnson
Janssen announced a research agreement to collaborate with GE Healthcare...
29 November 2010 | By The Scott Partnership
PharmaNet Development Group, Inc., announces that Chris Beaver, PhD has joined the Company as Director, Immunochemistry Services...
29 November 2010 | By GlaxoSmithKline
GlaxoSmithKline and Theravance, Inc. announced today that GSK will increase its shareholding in Theravance through the purchase of Theravance common stock in a private placement...
24 November 2010 | By Ethypharm
Zhong Chongyu has been appointed General Manager of Ethypharm in China. He reports to Alexandre Williams, Executive Vice President Business Development...
24 November 2010 | By Ethypharm
Frédéric Fougerat has been appointed Vice President Communications of the pharmaceutical company Ethypharm...
24 November 2010 | By MolMed S.p.A.
MolMed S.p.A. is pleased to announce the strengthening of its top management...
23 November 2010 | By F. Hoffmann-La Roche Ltd
Roche obtained a worldwide sublicense from Genzyme Corporation to develop a diagnostic assay for the detection of EGFR mutations...
22 November 2010 | By The Scott Partnership
PRECOS, has signed a significant service agreement with a leading global pharmaceutical company Janssen Pharmaceutica N.V...
22 November 2010 | By Abbott
Abbott announced positive results from a Phase 2 dose-ranging study of atrasentan...
22 November 2010 | By Syndicut
Convergence Pharmaceuticals and Selcia, announce that they have entered into a drug discovery collaboration...